Repligen Corp

RGEN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|VQLOCK|#&&SLOCK|f>$q@@H

Repligen Earnings: Strong Revenue Growth Across Portfolio Despite Slowdown in New Modalities

Repligen reported year-on-year revenue growth of 22% and adjusted operating margin of 14.2%, which is 70 basis points worse than the same period last year. The company narrowed its full-year guidance ranges and slightly raised its midpoint for revenue growth by 1 percentage point.

Sponsor Center